Keywords: novartis, files, trileptal, usa, filed, marketing, approval

Novartis Files For Trileptal In USA

Article | 06 October 1998

Print This

Novartis has filed for marketing approval in the USA for itsanti-epileptic drug Trileptal (oxcarbazepine), which has been available in some ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in